Medical Discoveries | Pharma Voice | Experimental | Safety Innovations | Certifications & Approvals | Laboratories
Fierce Pharma Asia—Takeda’s cell, gene therapy deals; BMS-BeiGene Abraxane brawl
Merck bags imperfect immunotherapy first with Keytruda cervical cancer approval
Bristol Myers Squibb is nixing BeiGene’s Abraxane deal in China amid manufacturing woes. Is their cancer rivalry really to blame?
Pharmapack Europe 2021 Award Winners Announced
Breathe Well-being reverses Type2 Diabetes, American Diabetes Association (ADA) acknowledges
Novartis exec says COVID exposed pharma manufacturing weaknesses. Here’s how he plans to fix them
Johnson & Johnson, Moderna COVID-19 vaccines work as intended, FDA staff say ahead of high-stakes booster meeting
Bristol Myers Squibb engaged in Acceleron buyout talks but couldn’t justify the price: report
Olympian joins Eli Lilly to level the field for health inequity in breast cancer
Research Grant For The Fight Against Blood Cancer
BOCA RATON, Fla.–(BUSINESS WIRE)–TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced the appointment of Mark Glickman as the Company’s Chief Business
NASHVILLE, Tenn.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the United States (U.S.) Food
SWORDS, Ireland–(BUSINESS WIRE)–Trane Technologies (NYSE: TT), a global climate innovator, has completed the acquisition of Farrar Scientific, which the company announced in a press release
FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN) will host a virtual investor event on November 9 at 4:00 p.m. ET. Topics to be covered at
– Data From PHYOX™2 Pivotal Trial of Nedosiran for Treatment of Primary Hyperoxaluria (PH) Accepted as Late-Breaker Poster Presentation – – Company on Track to
POTOMAC, Md.–(BUSINESS WIRE)–#Alzheimers–India Globalization Capital, Inc. (NYSE AMERICAN: IGC) announces that during its Annual Meeting of Shareholders scheduled for and convened on October 15, 2021,
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as
– Tecentriq is the first and only cancer immunotherapy approved for treatment of NSCLC in the adjuvant setting – – Approval based on the Phase
CHARLOTTETOWN, Prince Edward Island–(BUSINESS WIRE)–The Canadian Alliance for Skills and Training in Life Sciences (CASTL) is pleased to announce the appointment of Patrick Daoust as
Selecting Medicare plans in Texas is easier with Connie Health, which combines local agent expertise with advanced technology to help customers save money and get
